voriconazole has been researched along with Kidney Diseases in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Abualsunun, WA; Almalki, AJ; Bakhaidar, RB; Hegazy, MA; Hosny, KM; Kammoun, AK; Khedr, A; Murshid, SSA | 1 |
| Alameddine, R; Bazarbachi, A; El Cheikh, J; Mahfouz, R; Massoud, R; Nasr, R; Zahreddine, A; Zgheib, NK | 1 |
| Chen, L; Feng, Y; Lu, J; Xing, Y; Zhai, Y; Zhou, Y | 1 |
| Chen, J; Liu, W; Ma, Y; Meng, D; Wu, W; Xie, Z; Zhang, Q | 1 |
| Charles, JI; Jeanbourquin, D; Mostofi, K | 1 |
| Abib, SC; Alves, MT; Carlesse, F; Colombo, AL; Gonçalves, SS; Lederman, HM; Luisi, FA; Marcos, AC; Petrilli, AS; Ricci, G; Seber, A | 1 |
| Baietto, L; Bonora, S; Calcagno, A; D'Avolio, A; De Rosa, FG; Motta, I | 1 |
| Carter, JE; Culpepper, M; Goel, S; Kahn, AG | 1 |
| Corey, M | 1 |
| Inoue, T; Kakita, T; Matsuda, H; Mori, T; Nagatoya, K; Teranishi, J; Yamauchi, Y | 1 |
| Lombardi, LR; Marr, KA; Neofytos, D; Nguyen, MH; Ostrander, D; Shields, RK; Thompson, CB; Warren, L | 1 |
| Logan, BR; Zhang, MJ | 1 |
| Ullmann, AJ | 1 |
| Ermert, L; Lohmeyer, J; Lommel, D; Ludwig, M; Schneider, H; Sziegoleit, A; Weidner, W | 1 |
| Meessen, NE; Oosten, AW; Sprenger, HG; van Assen, S; van Leeuwen, JT | 1 |
| Andriole, VT; George, D; Miniter, P | 1 |
6 review(s) available for voriconazole and Kidney Diseases
| Article | Year |
|---|---|
Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections.
Topics: Antifungal Agents; Databases, Factual; Drug Tolerance; Humans; Invasive Fungal Infections; Kidney Diseases; Liver Diseases; Odds Ratio; Voriconazole | 2017 |
Cervical spondylitis due to Phaeoacremonium venezuelense in an immunocompetent patient. A first case report.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Cervical Vertebrae; Epidural Abscess; Humans; Immunocompetence; Kidney Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Mycoses; Pyrimidines; Species Specificity; Spondylitis; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Modern antifungal therapy for neutropenic fever.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fever; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Liposomes; Liver Diseases; Mycoses; Neutropenia; Pyrimidines; Triazoles; Voriconazole | 2006 |
Pharmacological aspects of the new triazole voriconazole.
Topics: Antifungal Agents; Contraindications; Drug Interactions; Humans; Kidney Diseases; Liver Diseases; Pyrimidines; Triazoles; Voriconazole | 2002 |
Systemic aspergillosis with predominant genitourinary manifestations in an immunocompetent man: what we can learn from a disastrous follow-up.
Topics: Abscess; Antifungal Agents; Aspergillosis; Caspofungin; Echinocandins; Humans; Kidney Diseases; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Peptides, Cyclic; Prostatic Diseases; Pyrimidines; Retroperitoneal Space; Triazoles; Voriconazole | 2005 |
Bilateral renal aspergillosis in a patient with AIDS: a case report and review of reported cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antiretroviral Therapy, Highly Active; Aspergillosis; Aspergillus fumigatus; HIV Infections; Humans; Kidney Diseases; Male; Pyrimidines; Radiography; Tomography Scanners, X-Ray Computed; Triazoles; Voriconazole | 2008 |
10 other study(ies) available for voriconazole and Kidney Diseases
| Article | Year |
|---|---|
Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles.
Topics: Animals; Antifungal Agents; Aspergillus flavus; Bacterial Outer Membrane Proteins; Biomarkers; Chemistry, Pharmaceutical; Clove Oil; Creatinine; Dose-Response Relationship, Drug; Drug Carriers; Drug Liberation; Gels; Kidney Diseases; Liposomes; Nanoparticles; Paranasal Sinuses; Particle Size; Rabbits; Rheology; Voriconazole | 2021 |
The role of candidate genetic polymorphisms in the interaction between voriconazole and cyclosporine in patients undergoing allogeneic hematopoietic cell transplantation: An explorative study.
Topics: Adult; Aged; Allografts; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; Biotransformation; Carrier Proteins; Cyclosporine; Cyclosporins; Cytochromes; Dose-Response Relationship, Drug; Drug Interactions; Female; Genetic Association Studies; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kidney Diseases; Male; Middle Aged; Pharmacogenomic Testing; Pilot Projects; Transplantation Conditioning; Voriconazole; Young Adult | 2020 |
A case of Phaeohyphomycosis caused by Corynespora cassiicola infection.
Topics: Aged; Ascomycota; Heart Failure; Humans; Kidney Diseases; Male; Phaeohyphomycosis; Voriconazole | 2018 |
Renal aspergillosis in a 6-year-old male with Burkitt's lymphoma.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Burkitt Lymphoma; Child; Humans; Kidney Diseases; Male; Voriconazole | 2015 |
A probable drug-to-drug interaction between voriconazole and haloperidol in a CYP2C19 poor metabolizing patient. [corrected].
Topics: Abscess; Adult; Antifungal Agents; Antipsychotic Agents; Aspergillosis; Cytochrome P-450 CYP2C19; Drug Interactions; Drug Monitoring; Haloperidol; HIV Infections; Humans; Immunocompromised Host; Kidney Diseases; Male; Voriconazole | 2015 |
Primary renal zygomycotic infarction mimicking renal neoplasia in an immunocompetent patient.
Topics: Adrenalectomy; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Humans; Immunocompetence; Kidney Diseases; Kidney Neoplasms; Male; Middle Aged; Nephrectomy; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole; Zygomycosis | 2009 |
Voriconazole-associated salt-losing nephropathy.
Topics: Aged; Antifungal Agents; Biomarkers; Chemical and Drug Induced Liver Injury; Fluid Therapy; Humans; Hyponatremia; Kidney Diseases; Liver; Male; Neurophysins; Protein Precursors; Pyrimidines; Renin; Sodium; Sodium Chloride; Time Factors; Treatment Outcome; Triazoles; Vasopressins; Voriconazole; Water-Electrolyte Balance | 2010 |
Administration of voriconazole in patients with renal dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Creatinine; Female; Humans; Infusions, Intravenous; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Mycoses; Pyrimidines; Renal Insufficiency; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2012 |
The use of group sequential designs with common competing risks tests.
Topics: Blood Platelets; Clinical Trials as Topic; Computer Simulation; Cord Blood Stem Cell Transplantation; Fluconazole; Humans; Kidney Diseases; Pyrimidines; Research Design; Risk; Sample Size; Statistics as Topic; Triazoles; Voriconazole | 2013 |
Efficacy of UK-109496, a new azole antifungal agent, in an experimental model of invasive aspergillosis.
Topics: Animals; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Azoles; Female; Kidney Diseases; Liver Diseases; Lung Diseases, Fungal; Pyrimidines; Rabbits; Triazoles; Voriconazole | 1996 |